RP- HPLC Method Development And Validation For Estimation Of Dapagliflozin In Tablet Formulation. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, p. 364–372, 2022. DOI: 10.47750/pnr.2022.13.S05.53. Disponível em: https://pnrjournal.com/index.php/home/article/view/1950.. Acesso em: 4 jun. 2026.